Analysis originally distributed on July 11, 2018 By: Michael Vodicka of Cannabis Stock Trades
June 26 was a groundbreaking day for the US cannabis industry.
That’s the day the FDA, the US agency responsible for approving new drug candidates, approved its first-ever cannabis drug.
The first-ever medical treatment derived from a marijuana plant will hit the U.S. market in a few months after regulators on Monday gave the epilepsy treatment the green light.
The Food and Drug Administration approved GW Pharmaceuticals Plc’s Epidiolex to treat two rare forms of childhood epilepsy, according to a statement from the agency. The liquid is made from a compound in the marijuana plant called cannabidiol, a different chemical from tetrahydrocannabinol, or THC, which gets users high.
First Marijuana-Based Medicine Is Approved for Sale in U.S.
This ruling is important for two reasons. Continue reading "Promising Cannabis Biotech Jumps 23%" →
Analysis originally distributed on May 10, 2018 By: Michael Vodicka of Cannabis Stock Trades
US cannabis stocks got a big jolt last month after President Trump promised to support cannabis.
After taking a short breather, it looks like US cannabis stocks are ready for another push higher.
The MJIC US cannabis index in a formation known as a Bullish Flag – a formation on the chart that frequently leads to an upside breakout and new high.
This Bull Flag is creating a great opportunity. If the index surges higher cannabis shareholders should pick up some nice gains.
Today – I want to reveal a promising young cannabis company headquartered in Canada that is making a big splash in the US cannabis market. Continue reading "Are US Cannabis Stocks Ready To Push Higher?" →
Analysis originally distributed on March 28, 2018 By: Michael Vodicka of Cannabis Stock Trades
Due to restrictive federal banking regulations, cannabis dispensaries are known to operate with large amounts of cash.
Copious amounts of cash have attracted criminal activity to the industry.
For example, in 2016 a security guard at a Colorado dispensary was killed.
In late summer 2017, a cannabis dispensary in San Fransisco was robbed of $600,000 in cannabis products.
Police say these kind of robberies are becoming more common.
If you poke around on the Internet, you will find hundreds of stories about criminals targeting cannabis dispensaries for cash and product.
Until the US cannabis industry is free from these restrictive federal banking regulations, cannabis dispensaries remain as hot targets for criminals.
While this is a speed bump in the long-term growth potential of the US cannabis industry, it's also creating a significant opportunity for a former military security specialist and his promising security company.
This little-known security company: Continue reading "Sales Jump 85% For Cannabis Security Company" →
Analysis originally distributed on October 4, 2017 By: Michael Vodicka of Cannabis Stock Trades
Growing revenue by more than 100% for 11 consecutive quarters is no small accomplishment.
A statistic like that immediately tells me two things about a company.
Number one, it is operating in a high-growth industry.
Number two, it is doing a great job of capturing that growth.
These are the reasons I'm excited about the little-known cannabis stock I am going to share today.
This early industry leader just reported its 11th consecutive quarter of at least 100% revenue growth.
That's a pretty ridiculous streak - I haven't seen anything like it even in the high-growth cannabis industry.
That's why shares are up 104% in 2017 and ready for more.
Let's take a closer look. Continue reading "100% Revenue Growth for 11 Consecutive Quarters" →